Feng Jung Sherida H. Woei-A-Jin

Also affiliated with Universitair Ziekenhuis Leuven, KU Leuven

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition”.

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Blood(2021)10.1182/blood.2021013338

N/A

0.757DataRank · unranked

155 citations

Jennifer Picarsic, Benjamin H. Durham, Zofia Hélias‐Rodzewicz, Laura S. Hiemcke‐Jiwa, Cor van den Bos +76 more

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2022)10.1007/s00428-021-03265-5

N/A

0DataRank · unranked

19 citations

Ruben A. L. de Groen, Rein Willemze, Patty M. Jansen, Koen D. Quint, Tom van Wezel +11 more

Genetic Stability of Driver Alterations in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type and Their Relapses: A Rationale for the Use of Molecular-Based Methods for More Effective Disease Monitoring

Cancers(2022)10.3390/cancers14205152

N/A

0DataRank · unranked

16 citations

Ruben A. L. de Groen, Rein Willemze, Patty M. Jansen, Koen D. Quint, Arjen Cleven +13 more

Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironment

Blood Cancer Journal(2025)10.1038/s41408-025-01291-z

N/A

0DataRank · unranked

4 citations

Fleur A. de Groot, Stefan Böhringer, Esther J Kret, Lorraine M. de Haan, Troy Noordenbos +33 more

398 | LACUTAMAB IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MYCOSIS FUNGOIDES: LONG TERM FOLLOW‐UP AND TRANSLATIONAL DATA FROM THE TELLOMAK PHASE 2 TRIAL

Hematological Oncology(2025)10.1002/hon.70094_398

N/A

0DataRank · unranked

0 citations

Martine Bagot, C. Ram‐Wolf, Auris Huen, Stéphane Dalle, Neha Mehta–Shah +16 more